Clinical Trials Sponsored by AmDerma

Total 332 results

Galderma R&D

Completed

A Treatment for Severe Inflammatory Acne Subjects

Acne Vulgaris

United States
Galderma R&D

Completed

Sculptra Chart Review

Non-facial Skin Aesthetic Conditions

United States
Galderma R&D

Completed

Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment

Aesthetics

Sweden, Brazil, France
Galderma R&D

Completed

A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion

Chin Retrusion | Chin Augmentation

United States
Galderma R&D

Completed

A 7-year Follow up of All Subjects Incuded in Protocol 31GB0106

Breast Augmentation

Sweden
Galderma R&D

Completed

Macrolane for Enhancement of the Shape and Fullness of the Female Breast

Breast Enhancement
Galderma R&D

Completed

Different Volumes of Durolane in Knee OA

Knee Osteoarthritis

Sweden
Galderma R&D

Completed

A Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride

Facial Tissue Augmentation

Sweden
Galderma R&D

Completed

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Platysmal Bands

United States
Galderma R&D

Completed

Safety and Efficacy of Restylane Vital for Skin Rejuvenation of Dorsal Hands

Dorsal Hands

China
Galderma R&D

Completed

Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root

Nasal Augmentation

China
Galderma R&D

Completed

Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars

Healthy Volunteers

Germany
Galderma R&D

Completed

A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds

Safety | Nasolabial Fold

Sweden
Galderma R&D

Completed

Open Label Extension for 43USSA1812

Wrinkle | Cheek

United States
Galderma R&D

Completed

Safety and Efficacy of Treatment With Azzalure, Restylane/Emervel Filler and Restylane Skinbooster

Facial Aesthetic Treatment

Sweden, France
Galderma R&D

Completed

A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers (05DF1707)

Volume Deficiency of the Midface

Germany, Italy, United Kingdom
Galderma R&D

Completed

GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Cheek Augmentation

United States
Galderma R&D

Completed

Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation

Cheek Augmentation | Midface Contour Deficiencies

United States
Galderma R&D

Terminated

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

Knee Osteoarthritis

United States
Galderma R&D

Completed

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Glabellar Frown Lines

United States
Galderma R&D

Completed

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Glabellar Frown Lines

United States
Galderma R&D

Completed

Durolane Versus Methylprednisolone in Knee Osteoarthritis

Knee Osteoarthritis

Canada, Sweden, United Kingdom
Galderma R&D

Completed

New Dermal Filler for Chin Correction and Augmentation

Chin Augmentation and Correction

Canada
Galderma R&D

Completed

Safety and Efficacy of Lip Injections With Emervel Lips and Juvederm Ultra Smile

Local Tolerability After Lip Filler Injections

Germany
Galderma R&D

Completed

Restylane Defyne for Correction of Chin Retrusion

Chin Retrusion

China
Galderma R&D

Completed

An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast

Breast Enhancement
Galderma R&D

Withdrawn

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction

Cheek Wrinkles | Midface Contour Deficiencies

Germany
Galderma R&D

Completed

A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines

Glabellar Frown Lines

Sweden
Galderma R&D

Completed

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Erythema | Rosacea

United States
Galderma R&D

Terminated

Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections

Nasolabial Folds

United States
Galderma R&D

Completed

Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.

Acne Prone Skin

United States
Galderma R&D

Completed

Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel

Acne Vulgaris

United States
Galderma R&D

Completed

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

Photoaging

United States
Galderma R&D

Completed

Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Emervel for the Correction of Lower Face Wrinkles & Folds

Wrinkles | Nasolabial Folds | Marionette Lines
Galderma R&D

Completed

Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo

Rosacea

United States
Galderma R&D

Completed

Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines

Wrinkles | Glabellar Lines

United States
Galderma R&D

Completed

Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion

Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion
Galderma R&D

Completed

An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%

Rosacea

United States
Galderma R&D

Completed

Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50

Skin Irritation

United States
Galderma R&D

Completed

Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30

Skin Irritation
Galderma R&D

Completed

Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face

Actinic Keratoses

United States, Puerto Rico
Galderma R&D

Completed

Extension Study for 43USSA1705

Nasolabial Folds

United States
Galderma R&D

Completed

Anesthetic Effect Duration Assessment

Healthy Volunteers

United States
Galderma R&D

Completed

Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)

Actinic Keratosis

United Kingdom
Galderma R&D

Completed

Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range (FIRST)

Aging

France, Spain, United Kingdom
Galderma R&D

Completed

Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Acne Scars

United States
Galderma R&D

Completed

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States, Canada
Galderma R&D

Completed

Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne (POWER)

Acne

Canada
Galderma R&D

Completed

Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris (TEAM)

Acne Vulgaris

Australia, Belgium, Brazil, France, Germany, Italy, Mexico, Poland, Sweden

3

Subscribe